ATE410163T1 - Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens - Google Patents

Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens

Info

Publication number
ATE410163T1
ATE410163T1 AT05711057T AT05711057T ATE410163T1 AT E410163 T1 ATE410163 T1 AT E410163T1 AT 05711057 T AT05711057 T AT 05711057T AT 05711057 T AT05711057 T AT 05711057T AT E410163 T1 ATE410163 T1 AT E410163T1
Authority
AT
Austria
Prior art keywords
zonisamide
diagnosis
treatment
osa
implementing
Prior art date
Application number
AT05711057T
Other languages
English (en)
Inventor
Jan Hedner
Ludger Grote
Kaj Stenloef
Original Assignee
Cereuscience Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cereuscience Ab filed Critical Cereuscience Ab
Application granted granted Critical
Publication of ATE410163T1 publication Critical patent/ATE410163T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/423Oxazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Test And Diagnosis Of Digital Computers (AREA)
AT05711057T 2004-02-17 2005-02-15 Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens ATE410163T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400378A SE0400378D0 (sv) 2004-02-17 2004-02-17 Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet

Publications (1)

Publication Number Publication Date
ATE410163T1 true ATE410163T1 (de) 2008-10-15

Family

ID=31974257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05711057T ATE410163T1 (de) 2004-02-17 2005-02-15 Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens

Country Status (14)

Country Link
US (1) US7655681B2 (de)
EP (1) EP1715859B1 (de)
JP (1) JP2007523079A (de)
CN (1) CN100558358C (de)
AT (1) ATE410163T1 (de)
AU (1) AU2005212149B2 (de)
CA (1) CA2555149C (de)
DE (1) DE602005010213D1 (de)
DK (1) DK1715859T3 (de)
ES (1) ES2317196T3 (de)
NZ (1) NZ548943A (de)
SE (1) SE0400378D0 (de)
SI (1) SI1715859T1 (de)
WO (1) WO2005077362A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2350327C2 (ru) 2003-04-29 2009-03-27 Ориксиджен Серапьютикс, Инкорпорэйтд Составы, вызывающие потерю веса
CA2622721A1 (en) * 2005-09-16 2007-03-22 Cereuscience Ab Method and means of preventing and treating sleep disordered breathing
EP1951212A2 (de) 2005-11-22 2008-08-06 Orexigen Therapeutics, Inc. Zusammensetzungen und verfahren zur erhöhung der insulinsensitivität
AR057946A1 (es) * 2005-11-28 2007-12-26 Orexigen Therapeutics Inc Formulacion de zonisamida de liberacion sostenidda
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
CA2668885C (en) 2006-11-09 2016-08-02 Orexigen Therapeutics, Inc. Methods for administering weight loss medications
EP2303025A4 (de) 2008-05-30 2012-07-04 Orexigen Therapeutics Inc Verfahren zur behandlung von eingeweidefettbeschwerden
KR20120101588A (ko) * 2010-01-07 2012-09-13 비버스 인크. 탄산탈수효소 억제제 및 추가적인 활성제의 조합에 의한 폐쇄 수면 무호흡 증후군의 치료
EP3659604A1 (de) 2010-01-11 2020-06-03 Nalpropion Pharmaceuticals, Inc. Verfahren zur bereitstellung einer gewichtsverlusttherapie für patienten mit schweren depressionen
EP4154804A1 (de) * 2012-05-30 2023-03-29 ResMed Sensor Technologies Limited Vorrichtung zur überwachung der herz-lungen-gesundheit
PT3730132T (pt) 2012-06-06 2022-08-16 Nalpropion Pharmaceuticals Llc Composição para utilização num método de tratamento de excesso de peso e obesidade em doentes com alto risco cardiovascular
US10525219B2 (en) 2012-06-26 2020-01-07 Resmed Sensor Technologies Limited Methods and apparatus for monitoring and treating respiratory insufficiency
PL3423062T3 (pl) 2016-05-11 2020-12-28 Jan Hedner Sultiam do leczenia bezdechu sennego
CN112259179A (zh) * 2020-10-09 2021-01-22 首都医科大学宣武医院 一种患者日志生成方法及装置
US20240306982A1 (en) * 2023-03-16 2024-09-19 Laura Schneider Method for treating sleep apnea/hypopnea

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489350B1 (en) * 1999-09-15 2002-12-03 Elan Pharmaceuticals, Inc. Methods for treating neuropathic pain using heteroarylmethanesulfonamides
SE0000601D0 (sv) * 2000-02-24 2000-02-24 Jan Hedner Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
JP4545584B2 (ja) * 2002-05-17 2010-09-15 デューク ユニバーシティ 肥満を治療するための方法

Also Published As

Publication number Publication date
SE0400378D0 (sv) 2004-02-17
JP2007523079A (ja) 2007-08-16
CN100558358C (zh) 2009-11-11
NZ548943A (en) 2010-06-25
EP1715859B1 (de) 2008-10-08
ES2317196T3 (es) 2009-04-16
US20070281005A1 (en) 2007-12-06
DE602005010213D1 (de) 2008-11-20
AU2005212149B2 (en) 2010-02-11
EP1715859A1 (de) 2006-11-02
WO2005077362A1 (en) 2005-08-25
AU2005212149A1 (en) 2005-08-25
CA2555149A1 (en) 2005-08-25
CN1917874A (zh) 2007-02-21
SI1715859T1 (sl) 2009-06-30
US7655681B2 (en) 2010-02-02
DK1715859T3 (da) 2009-02-16
CA2555149C (en) 2014-01-21

Similar Documents

Publication Publication Date Title
Yap et al. Sleep bruxism: Current knowledge and contemporary management
ATE410163T1 (de) Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
EA200800663A1 (ru) Способ и средство профилактики и лечения нарушенного дыхания во время сна
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
DE602005018763D1 (de) Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
EA200800007A1 (ru) Фармацевтические композиции на основе нейроактивного стероида и их применение
RU2008150622A (ru) Лечение агонистом мелатонина
MX2012007813A (es) Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
WO2008022189A3 (en) Administration of high potency platinum compound formulations by inhalation
EA200700214A1 (ru) Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией
JP2009537553A5 (de)
MX2008013635A (es) Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
JP2004532215A (ja) 睡眠時の自律的安定性に関するカンナビノイドの機能的役割
DE60111025D1 (de) Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose
BRPI0510501A (pt) antagonistas do receptor 3 de histamina
BRPI0513444A (pt) antagonistas do receptor da histamina 3
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
NO20064964L (no) Behandling av svekket respiratorisk funksjon
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
JP2013510187A (ja) 誘発されたジスキネジアを治療又は予防するためのキセノンベースの吸入可能薬物
EP1262197A3 (de) Kombinationstherapie zur Behandlung von Schlafstörungen, Schlaflosigkeit inbegriffen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties